LifeVantage Corp (NASDAQ: LFVN) is a direct-selling health and wellness company that sells dietary supplements, skin and hair care products, and nootropic energy products through a network of independent consultants. Revenue comes primarily from product sales to independent consultants and end customers, with consultants earning commissions on their own purchases and on sales generated through their personal marketing organizations. As of June 30, 2025, LifeVantage had 51,000 active independent consultants and 81,000 active customers, totaling 132,000 active accounts globally. The company operates across the Americas (75.8% of active accounts as of June 30, 2025) and Asia/Pacific and Europe (24.2%). LifeVantage is headquartered in the United States and sells products in 17 named markets including the United States, Japan, Australia, Canada, and the United Kingdom. The company paid aggregate dividends of $0.165 per share for the fiscal year ended June 30, 2025, with 12.4 million shares outstanding as of June 30, 2025.

Revenue model

Product sales transacted directly through the company's website and toll-free ordering channels, paid by credit card prior to shipment. Independent consultants earn commissions on product sales to their customers and on sales within their recruited networks. Commissions on consultant personal purchases are treated as a sales discount and reduce net revenue. Additional revenue streams include fee revenue and shipping and handling fees.

Products and services

Protandim line of dietary supplements (NRF1 Synergizer, Nrf2 Synergizer, NAD Synergizer); LifeVantage dietary supplements including MindBody GLP-1 System, Omega+, ProBio, IC Bright, Rise AM and Reset PM System, D3+, and Daily Wellness; PhysIQ Fat Burn and PhysIQ Prebiotic dietary supplements; TrueScience skin and hair care line (cleansers, moisturizers, eye cream, sunstick, shampoo, conditioner, scalp serum, Liquid Collagen); Petandim pet supplement for dogs; AXIO nootropic energy drink mixes. Products are sold individually and in bundled stacks.

Customers and end markets

End consumers purchasing health, wellness, and personal care products for personal use. Independent consultants who purchase for personal use and resell to their own customer networks. As of June 30, 2025, 51,000 active independent consultants and 81,000 active customers. Americas-based accounts represent 75.8% of total active accounts; Asia/Pacific and Europe represent 24.2%.

Value-chain role

Product developer and manufacturer-to-consumer seller operating through a multi-level direct-selling distribution model. The company develops proprietary formulations grounded in nutrigenomics, pre-approves all sales and marketing materials used by independent consultants, and handles order processing, customer service, and fulfillment directly.

Geographic exposure

Americas: 75.8% of active accounts as of June 30, 2025. Asia/Pacific and Europe: 24.2% of active accounts as of June 30, 2025. Named markets include the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore. Philippines operations ceased June 30, 2025.

Source: SEC 10-K, filed 2025-09-04

Industry: Pharmaceutical Preparations Peers: ALTEROLA BIOTECH INC. LifeMD Inc Estee Lauder Companies Inc High Sierra Technologies, Inc. Zivo Bioscience Inc Mannatech Inc TWINLAB CONSOLIDATED HOLDINGS, INC. Natural Alternatives International Inc United-Guardian Inc